Eloxx Pharmaceuticals, Inc. (ELOX)

PriceLoading quote

Financial charts

Revenue

Net income

Free cash flow

Total cash / debt

CashTotal debt

Financial statements

26 annual periodsNewest to oldest
2025202220212020201920182017 · Dec 312017 · Jun 30201620152014201320122011201020092008200720062005200420032002200120001999
Revenue$0$182,229$7,819$200,000$140,000
Research & development$3.1M$23.7M$22.9M$14.6M$26.3M$20.5M$16.4M$733,661$2.2M$4.6M$3.3M$2.1M$2.6M$3.7M$2.6M
Operating expenses$6.4M$34.4M$66.0M$33.5M$50.6M$47.6M$20.4M
Operating income−$6.4M−$34.4M−$66.0M−$33.5M−$50.6M−$47.6M−$20.4M−$4.6M−$11.2M−$18.1M−$9.1M−$4.7M−$5.4M−$7.9M−$4.8M
EBITDAderived−$4.5M−$11.1M−$17.9M−$8.8M−$4.4M−$5.2M−$7.8M−$4.7M
Net income−$6.0M−$36.1M−$66.7M−$34.6M−$50.9M−$47.2M−$21.2M−$5.8M−$8.3M−$18.1M−$9.2M−$6.1M−$5.1M−$7.3M−$13.4M−$5.7M−$4.6M−$3.3M−$3.3M−$3.0M−$3.7M−$2.8M−$3.0M−$2.0M−$3.3M−$1.2M
Basic EPSper diluted share-$0.49-$16.65-$38.15-$0.86-$1.34-$1.45-$4.75-$0.27-$0.42-$1.31-$2.53-$5.11-$7.81-$0.14-$0.67
Diluted EPSper diluted share-$0.49-$16.65-$38.15-$0.86-$1.34-$1.45-$4.75-$0.27-$0.42-$1.31-$2.53-$5.11-$7.81-$0.14-$0.67

Insider buys & sells

Jul 1, 2024Jun 30, 2026
Buys0$0.00 disclosed value
Sells (SEC code S)0$0.00 disclosed value
0 recent transactions
No insider transactions transactions were reported in the stored SEC coverage.